Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glial Cells01:04

Glial Cells

Overview
Nervous Tissue: Glial Cells01:31

Nervous Tissue: Glial Cells

Glia, or neuroglia, are vital support cells that assist neurons in their functions. The term "glia" originates from the Greek word for "glue," reflecting their role in holding the nervous system together. These cells can be categorized into six types: four in the central nervous system (CNS) and two in the peripheral nervous system (PNS).
The CNS glial cell includes the astrocytes, the oligodendrocytes, the microglia, and the ependymal cells.
Astrocytes are star-shaped glial cells that interact...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cognitive impairments associated with meningiomas and gliomas in adults: A systematic review.

Neuropsychology·2026
Same author

Effect of APOC3 Inhibition With Olezarsen on Coronary Atherosclerosis: Essence-TIMI 73b Imaging Study.

Circulation·2026
Same author

Pathologic Variability Associated With Phenotypic Differences in Siblings With ACTA1 Myopathy.

Muscle & nerve·2026
Same author

Antibody-mediated LOX-1 inhibition in patients with residual inflammation after myocardial infarction: a randomized phase 2 trial.

Nature medicine·2025
Same author

Editorial: Endocrinology, lipids, and disease: unraveling the links.

Frontiers in endocrinology·2025
Same author

A data-driven journey using results from target-based drug discovery for target deconvolution in phenotypic screening.

RSC medicinal chemistry·2025

Related Experiment Video

Updated: Jun 23, 2026

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
12:52

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

Galectins and gliomas.

Marie Le Mercier1, Shannon Fortin, Véronique Mathieu

  • 1Laboratory of Toxicology; Institute of Pharmacy, Universite Libre de Bruxelles, Brussels, Belgium.

Brain Pathology (Zurich, Switzerland)
|April 18, 2009
PubMed
Summary

Malignant gliomas like glioblastoma have poor prognoses due to invasive growth and drug resistance. Galectins, particularly galectin-1 and galectin-3, are key players in glioma progression and may be therapeutic targets.

More Related Videos

Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions
07:39

Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions

Published on: November 17, 2021

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
05:45

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Published on: July 31, 2017

Related Experiment Videos

Last Updated: Jun 23, 2026

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
12:52

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions
07:39

Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions

Published on: November 17, 2021

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
05:45

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Published on: July 31, 2017

Area of Science:

  • Neuro-oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Malignant gliomas, particularly glioblastomas, present a poor prognosis with limited median survival.
  • Glioma cell infiltration and apoptosis resistance contribute to therapeutic challenges.
  • Galectins, beta-galactoside-binding proteins, are implicated in various cellular processes, including cancer.

Purpose of the Study:

  • To review the role of galectins, specifically galectin-1 and galectin-3, in glioma biology.
  • To explore galectin involvement in glioma progression mechanisms.
  • To assess galectins as potential therapeutic targets for malignant gliomas.

Main Methods:

  • Literature review focusing on galectin expression and function in gliomas.
  • Analysis of galectin roles in glioma cell migration, angiogenesis, and chemoresistance.
  • Synthesis of current knowledge on galectins in glioma pathogenesis.

Main Results:

  • Galectins, especially galectin-1 and galectin-3, are differentially expressed in gliomas.
  • These galectins are involved in critical steps of glioma progression, including invasion and vascularization.
  • Galectins contribute to resistance against chemotherapy in glioma cells.

Conclusions:

  • Galectin-1 and galectin-3 play significant roles in malignant glioma progression.
  • Targeting galectins may offer a novel therapeutic strategy for glioblastoma.
  • Further research into galectin-targeted therapies is warranted for improved glioma treatment.